Yangying Zhou - Search Results

Year	Number of Results
2017	4
2018	7
2019	10
2020	16
2021	3
2022	7
2023	11
2024	3

1

Causal relationship between gut microbiota and cancers: a two-sample Mendelian randomisation study.

Long Y, Tang L, Zhou Y, Zhao S, Zhu H. Long Y, et al. Among authors: zhou y. BMC Med. 2023 Feb 21;21(1):66. doi: 10.1186/s12916-023-02761-6. BMC Med. 2023. PMID: 36810112 Free PMC article.

2

Angiogenesis stimulated by elevated PDGF-BB in subchondral bone contributes to osteoarthritis development.

Su W, Liu G, Liu X, Zhou Y, Sun Q, Zhen G, Wang X, Hu Y, Gao P, Demehri S, Cao X, Wan M. Su W, et al. Among authors: zhou y. JCI Insight. 2020 Apr 23;5(8):e135446. doi: 10.1172/jci.insight.135446. JCI Insight. 2020. PMID: 32208385 Free PMC article.

3

Identification and validation of a tyrosine metabolism-related prognostic prediction model and characterization of the tumor microenvironment infiltration in hepatocellular carcinoma.

Zhou Y, Li X, Long G, Tao Y, Zhou L, Tang J. Zhou Y, et al. Front Immunol. 2022 Oct 20;13:994259. doi: 10.3389/fimmu.2022.994259. eCollection 2022. Front Immunol. 2022. PMID: 36341373 Free PMC article.

4

PAX1 hypomethylation as a prognostic biomarker for radioresistance of cervical cancer.

Li X, Liu H, Zhou X, Zhou Y, Zhang Y, Liou YL, Zeng M, Zhu H. Li X, et al. Among authors: zhou y. Clin Epigenetics. 2023 Aug 2;15(1):123. doi: 10.1186/s13148-023-01538-1. Clin Epigenetics. 2023. PMID: 37533109 Free PMC article.

5

The deubiquitinase EIF3H promotes hepatocellular carcinoma progression by stabilizing OGT and inhibiting ferroptosis.

Tang J, Long G, Li X, Zhou L, Zhou Y, Wu Z. Tang J, et al. Among authors: zhou y. Cell Commun Signal. 2023 Aug 9;21(1):198. doi: 10.1186/s12964-023-01220-2. Cell Commun Signal. 2023. PMID: 37559097 Free PMC article.

6

The Antitumor Activities of Marsdenia tenacissima.

Wang X, Yan Y, Chen X, Zeng S, Qian L, Ren X, Wei J, Yang X, Zhou Y, Gong Z, Xu Z. Wang X, et al. Among authors: zhou y. Front Oncol. 2018 Oct 23;8:473. doi: 10.3389/fonc.2018.00473. eCollection 2018. Front Oncol. 2018. PMID: 30406035 Free PMC article. Review.

7

AP4M1 as a prognostic biomarker associated with cell proliferation, migration and immune regulation in hepatocellular carcinoma.

Peng Y, Li X, Kang K, Zhou Y. Peng Y, et al. Among authors: zhou y. Cancer Cell Int. 2023 Oct 11;23(1):235. doi: 10.1186/s12935-023-03089-0. Cancer Cell Int. 2023. PMID: 37821948 Free PMC article.

8

Sulforaphane: Expected to Become a Novel Antitumor Compound.

Wu G, Yan Y, Zhou Y, Duan Y, Zeng S, Wang X, Lin W, Ou C, Zhou J, Xu Z. Wu G, et al. Among authors: zhou y. Oncol Res. 2020 Sep 1;28(4):439-446. doi: 10.3727/096504020X15828892654385. Epub 2020 Feb 28. Oncol Res. 2020. PMID: 32111265 Free PMC article. Review.

9

CircPVT1: a bridge linking Hippo pathway and human cancers.

He X, Su W, Zhou Y, Ge X, Zhou J, Ou C. He X, et al. Among authors: zhou y. Ann Transl Med. 2018 Dec;6(Suppl 2):S91. doi: 10.21037/atm.2018.11.06. Ann Transl Med. 2018. PMID: 30740412 Free PMC article. No abstract available.

10

AhR Promotes the Development of Non-small cell lung cancer by Inducing SLC7A11-dependent Antioxidant Function.

Peng Y, Ouyang L, Zhou Y, Lai W, Chen Y, Wang Z, Yan B, Zhang Z, Zhou Y, Peng X, Chen J, Peng X, Xiao D, Liu S, Tao Y, Liu W. Peng Y, et al. Among authors: zhou y. J Cancer. 2023 Mar 27;14(5):821-834. doi: 10.7150/jca.82066. eCollection 2023. J Cancer. 2023. PMID: 37056388 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

59 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year